How the PDE6 enzyme keeps rod cells healthy
The complex role of phosphodiesterase 6 in rod photoreceptor health and function
This work learns how the PDE6 enzyme supports rod photoreceptors to help people with inherited rod-related retinal degeneration preserve vision.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California-Irvine NIH-funded |
| Lab location | 1 site (Irvine, United States) |
| Project ID | NIH-11375120 on NIH RePORTER |
What this research studies
This project looks at the two protein parts (alpha and beta) of the PDE6 enzyme that power rod cells in the retina. Scientists will use lab-based biochemical and structural approaches and genetically altered models to disable or trim parts of PDE6 and see how that changes the enzyme and rod cell organization. The team will combine detailed protein structure information with in vivo experiments to link specific subunit changes to rod cell stability and function. Findings aim to explain how PDE6 defects lead to retinal degeneration and point to targets for future therapies.
Who could benefit from this research
Good fit: People with inherited rod-dominant retinal degenerations (for example, PDE6-linked retinitis pigmentosa) would be most relevant to this research.
Not a fit: Patients whose vision loss stems from non-rod causes or advanced macular disease not linked to PDE6 are unlikely to benefit directly from this project.
Why it matters
Potential benefit: If successful, this work could clarify how specific PDE6 defects cause rod-cell loss and guide the development of treatments that protect or restore vision in PDE6-related retinopathies.
How similar studies have performed: Related structural and biochemical studies on other photoreceptor proteins have illuminated disease mechanisms, but detailed in vivo subunit dissection of PDE6 is relatively novel.
Where this research is happening
Irvine, United States
- University of California-Irvine — Irvine, United States (Active)
Researchers
- Principal investigator: Palczewski, Krzysztof — University of California-Irvine
- Study coordinator: Palczewski, Krzysztof
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.